Introduction: The damage in the endothelium and the neurovascular unit appears to play a key role in the pathogenesis of vascular cognitive impairment (VCI). Although there have been many advances in understanding the physiopathology of this disease, several questions remain unanswered. The association with other degenerative diseases and the heterogeneity of its clinical spectrum establish a diagnostic problem, compromising a better comprehension of the pathology and halting the development of effective treatments. The investigation of biomarkers is an important movement to the development of novel explicative models and treatment targets involved in VCI. Methods: We searched MEDLINE considering the original research based on VCI biomarkers in the past 20 years, following prespecified selection criteria, data extraction, and qualitative synthesis. Results: We reviewed 42 articles: 16 investigated plasma markers, 17 analyzed neuropathological markers, 4 studied CSF markers, 4 evaluated neuroimaging markers (ultrasound and MRI), and 1 used peripheral Doppler perfusion imaging. Conclusions: The biomarkers in these studies suggest an intrinsic relationship between endothelial dysfunction and VCI. Nonetheless, there is still a need for identification of a distinctive set of markers that can integrate the clinical approach of VCI, improve diagnostic accuracy, and support the discovery of alternative therapies.

1.
Wardlaw
JM
,
Smith
C
,
Dichgans
M
.
Small vessel disease: mechanisms and clinical implications
.
Lancet Neurol
.
2019
Jul
;
18
(
7
):
684
96
.
[PubMed]
1474-4422
2.
Pantoni
L
.
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
.
Lancet Neurol
.
2010
Jul
;
9
(
7
):
689
701
.
[PubMed]
1474-4422
3.
Mok
V
,
Wong
A
,
Tang
WK
,
Lam
WW
,
Fan
YH
,
Richards
PS
, et al.
Determinants of prestroke cognitive impairment in stroke associated with small vessel disease
.
Dement Geriatr Cogn Disord
.
2005
;
20
(
4
):
225
30
.
[PubMed]
1420-8008
4.
Huisa
BN
,
Caprihan
A
,
Thompson
J
,
Prestopnik
J
,
Qualls
CR
,
Rosenberg
GA
.
Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease
.
Stroke
.
2015
Sep
;
46
(
9
):
2413
8
.
[PubMed]
0039-2499
5.
Shibata
M
,
Yamada
S
,
Kumar
SR
,
Calero
M
,
Bading
J
,
Frangione
B
, et al.
Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
.
J Clin Invest
.
2000
Dec
;
106
(
12
):
1489
99
.
[PubMed]
0021-9738
6.
Zlokovic
BV
,
Yamada
S
,
Holtzman
D
,
Ghiso
J
,
Frangione
B
.
Clearance of amyloid beta-peptide from brain: transport or metabolism?
Nat Med
.
2000
Jul
;
6
(
7
):
718
9
. 1078-8956
7.
Snyder
HM
,
Corriveau
RA
,
Craft
S
,
Faber
JE
,
Greenberg
SM
,
Knopman
D
, et al.
Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease
.
Alzheimers Dement
.
2015
Jun
;
11
(
6
):
710
7
.
[PubMed]
1552-5260
8.
Moher
D
,
Liberati
A
,
Tetzlaff
J
,
Altman
DG
,
PRISMA Group.
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, vol. 6, no. 7. Jul-2009.
9.
Janelidze
S
,
Hertze
J
,
Nagga
K
,
Nilsson
K
,
Nilsson
C
,
Wennstrom
M
, et al.
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
Neurobiol. Aging, vol. 51, no. 2017, pp. 104–112,
2017
.
10.
Skoog
I
.
Risk factors for vascular dementia: a review
.
Dementia
.
1994
May-Aug
;
5
(
3-4
):
137
44
.
[PubMed]
1013-7424
11.
Carantoni
M
,
Zuliani
G
,
Munari
MR
,
D’Elia
K
,
Palmieri
E
,
Fellin
R
.
Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels
.
Dement Geriatr Cogn Disord
.
2000
May-Jun
;
11
(
3
):
176
80
.
[PubMed]
1420-8008
12.
Han
JH
,
Wong
KS
,
Wang
YY
,
Fu
JH
,
Ding
D
,
Hong
Z
.
Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects
.
Clin Neurol Neurosurg
.
2009
Dec
;
111
(
10
):
847
51
.
[PubMed]
0303-8467
13.
Zuliani
G
,
Cavalieri
M
,
Galvani
M
,
Passaro
A
,
Munari
MR
,
Bosi
C
, et al.
Markers of endothelial dysfunction in older subjects with late onset Alzheimer’s disease or vascular dementia
.
J Neurol Sci
.
2008
Sep
;
272
(
1-2
):
164
70
.
[PubMed]
0022-510X
14.
Staszewski
J
,
Piusińska-Macoch
R
,
Brodacki
B
,
Skrobowska
E
,
Stępień
A
.
IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study
.
Clin Interv Aging
.
2018
Jun
;
13
:
1135
41
.
[PubMed]
1176-9092
15.
Dias
HK
,
Brown
CL
,
Polidori
MC
,
Lip
GY
,
Griffiths
HR
.
LDL-lipids from patients with hypercholesterolaemia and Alzheimer’s disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention
.
Clin Sci (Lond)
.
2015
Dec
;
129
(
12
):
1195
206
.
[PubMed]
0143-5221
16.
Miralbell
J
,
López-Cancio
E
,
López-Oloriz
J
,
Arenillas
JF
,
Barrios
M
,
Soriano-Raya
JJ
, et al.
Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors
.
Cerebrovasc Dis
.
2013
;
36
(
2
):
98
105
.
[PubMed]
1015-9770
17.
Holm
H
,
Nagga
K
,
Nilsson
ED
,
Ricci
F
,
Melander
O
,
Hansson
O
, et al.
Biomarkers of microvascular endothelial dysfunction predict incident dementia : a population-based prospective study. J Intern Med. 2017 no. Cv, pp. 94–101,
2017
.
18.
Qiang
G
,
Wenzhai
C
,
Huan
Z
,
Yuxia
Z
,
Dongdong
Y
,
Sen
Z
, et al.
Effect of Sancaijiangtang on plasma nitric oxide and endothelin-1 levels in patients with type 2 diabetes mellitus and vascular dementia : a single-blind randomized controlled trial. J Tradit Chin Med. 2015 Aug, vol. 35, no. 4, pp. 375–380,
2015
.
19.
Pikula
A
,
Böger
RH
,
Beiser
AS
,
Maas
R
,
DeCarli
C
,
Schwedhelm
E
, et al.
Association of plasma ADMA levels with MRI markers of vascular brain injury: framingham offspring study
.
Stroke
.
2009
Sep
;
40
(
9
):
2959
64
.
[PubMed]
0039-2499
20.
Pelzer
N
,
Bijkerk
R
,
Reinders
ME
,
van Zonneveld
AJ
,
Ferrari
MD
,
van den Maagdenberg
AM
, et al.
Circulating endothelial markers in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
.
Stroke
.
2017
Dec
;
48
(
12
):
3301
7
.
[PubMed]
0039-2499
21.
Stott
DJ
,
Spilg
E
,
Campbell
AM
,
Rumley
A
,
Mansoor
MA
,
Lowe
GD
.
Haemostasis in ischaemic stroke and vascular dementia
.
Blood Coagul Fibrinolysis
.
2001
Dec
;
12
(
8
):
651
7
.
[PubMed]
0957-5235
22.
Briani
C
,
Cagnin
A
,
Gallo
L
,
Toffanin
E
,
Varagnolo
M
,
Zaninotto
M
, et al.
Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology?
J Neurol Sci
.
2005
Mar
;
229-230
:
215
8
.
[PubMed]
0022-510X
23.
Lin
JX
,
Tomimoto
H
,
Akiguchi
I
,
Matsuo
A
,
Wakita
H
,
Shibasaki
H
, et al.
Vascular cell components of the medullary arteries in Binswanger’s disease brains: a morphometric and immunoelectron microscopic study
.
Stroke
.
2000
Aug
;
31
(
8
):
1838
42
.
[PubMed]
0039-2499
24.
Ashby
EL
,
Kehoe
PG
,
Love
S
.
Kallikrein-related peptidase 6 in Alzheimer’s disease and vascular dementia
.
Brain Res
.
2010
Dec
;
1363
:
1
10
.
[PubMed]
0006-8993
25.
Lemańska-Perek
A
,
Leszek
J
,
Krzyzanowska-Gołab
D
,
Radzik
J
,
Ka̧tnik-Prastowska
I
.
Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer’s dementia risk
.
Dement Geriatr Cogn Disord
.
2009
;
28
(
4
):
338
42
.
[PubMed]
1420-8008
26.
Romanitan
MO
,
Popescu
BO
,
Spulber
S
,
Băjenaru
O
,
Popescu
LM
,
Winblad
B
, et al.
Altered expression of claudin family proteins in Alzheimer’s disease and vascular dementia brains
.
J Cell Mol Med
.
2010
May
;
14
(
5
):
1088
100
.
[PubMed]
1582-4934
27.
Romanitan
MO
,
Popescu
BO
,
Winblad
B
,
Bajenaru
OA
,
Bogdanovic
N
.
Occludin is overexpressed in Alzheimer’s disease and vascular dementia
.
J Cell Mol Med
.
2007
May-Jun
;
11
(
3
):
569
79
.
[PubMed]
1582-1838
28.
Ke
XJ
,
Zhang
JJ
.
Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction
.
J Huazhong Univ Sci Technolog Med Sci
.
2013
Jun
;
33
(
3
):
433
7
.
[PubMed]
1672-0733
29.
Tarkowski
E
,
Issa
R
,
Sjögren
M
,
Wallin
A
,
Blennow
K
,
Tarkowski
A
, et al.
Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia
.
Neurobiol Aging
.
2002
Mar-Apr
;
23
(
2
):
237
43
.
[PubMed]
0197-4580
30.
Chakraborty
A
,
Chatterjee
M
,
Twaalfhoven
H
,
Del Campo Milan
M
,
Teunissen
CE
,
Scheltens
P
, et al.
Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia
.
Alzheimers Res Ther
.
2018
Jun
;
10
(
1
):
58
.
[PubMed]
1758-9193
31.
Ahmed-Jushuf
F
,
Jiwa
NS
,
Arwani
AS
,
Foot
P
,
Bridges
LR
,
Kalaria
RN
, et al.
Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brains
.
Neurobiol Aging
.
2016
Jun
;
42
:
110
5
.
[PubMed]
0197-4580
32.
Solerte
SB
,
Ferrari
E
,
Cuzzoni
G
,
Locatelli
E
,
Giustina
A
,
Zamboni
M
, et al.
Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer’s disease: recovering effect with insulin and DHEA sulfate
.
Dement Geriatr Cogn Disord
.
2005
;
19
(
1
):
1
10
.
[PubMed]
1420-8008
33.
Kim
Y
,
Nam
YJ
,
Lee
C
.
Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia
.
Am J Med Genet B Neuropsychiatr Genet
.
2006
Jun
;
141B
(
4
):
332
5
.
[PubMed]
1552-4841
34.
Hohman
TJ
,
Bell
SP
,
Jefferson
AL
;
Alzheimer’s Disease Neuroimaging Initiative
.
The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease
.
JAMA Neurol
.
2015
May
;
72
(
5
):
520
9
.
[PubMed]
2168-6149
35.
Baloyannis
SJ
.
Pathological alterations of the climbing fibres of the cerebellum in vascular dementia: a Golgi and electron microscope study
.
J Neurol Sci
.
2007
Jun
;
257
(
1-2
):
56
61
.
[PubMed]
0022-510X
36.
Burke
MJ
,
Nelson
L
,
Slade
JY
,
Oakley
AE
,
Khundakar
AA
,
Kalaria
RN
.
Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias
.
Neuropathol Appl Neurobiol
.
2014
Apr
;
40
(
3
):
284
95
.
[PubMed]
0305-1846
37.
Barker
R
,
Ashby
EL
,
Wellington
D
,
Barrow
VM
,
Palmer
JC
,
Kehoe
PG
, et al.
Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
.
Brain
.
2014
May
;
137
(
Pt 5
):
1524
32
.
[PubMed]
0006-8950
38.
Thomas
T
,
Miners
S
,
Love
S
.
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia
.
Brain
.
2015
Apr
;
138
(
Pt 4
):
1059
69
.
[PubMed]
0006-8950
39.
Sinclair
LI
,
Tayler
HM
,
Love
S
.
Synaptic protein levels altered in vascular dementia
.
Neuropathol Appl Neurobiol
.
2015
Jun
;
41
(
4
):
533
43
.
[PubMed]
0305-1846
40.
Babapoor-Farrokhran
S
,
Jee
K
,
Puchner
B
,
Hassan
SJ
,
Xin
X
,
Rodrigues
M
, et al.
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
.
Proc Natl Acad Sci USA
.
2015
Jun
;
112
(
23
):
E3030
9
.
[PubMed]
0027-8424
41.
Chakraborty
A
,
Kamermans
A
,
van Het Hof
B
,
Castricum
K
,
Aanhane
E
,
van Horssen
J
, et al.
Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathy
.
Brain
.
2018
Dec
;
141
(
12
):
3377
88
.
[PubMed]
0006-8950
42.
Shimada
K
,
Matsushita
Y
,
Wakabayashi
K
,
Takahashi
M
,
Matsubara
A
,
Iijima
Y
, et al.
Cloning and functional expression of human endothelin-converting enzyme cDNA
.
Biochem Biophys Res Commun
.
1995
Feb
;
207
(
2
):
807
12
.
[PubMed]
0006-291X
43.
Palmer
JC
,
Baig
S
,
Kehoe
PG
,
Love
S
.
Endothelin-converting enzyme-2 is increased in Alzheimer’s disease and up-regulated by Abeta
.
Am J Pathol
.
2009
Jul
;
175
(
1
):
262
70
.
[PubMed]
0002-9440
44.
Giwa
MO
,
Williams
J
,
Elderfield
K
,
Jiwa
NS
,
Bridges
LR
,
Kalaria
RN
, et al.
Neuropathologic evidence of endothelial changes in cerebral small vessel disease
.
Neurology
.
2012
Jan
;
78
(
3
):
167
74
.
[PubMed]
0028-3878
45.
Staszewski
J
,
Skrobowska
E
,
Piusińska-Macoch
R
,
Brodacki
B
,
Stępień
A
.
Cerebral and Extracerebral Vasoreactivity in Patients With Different Clinical Manifestations of Cerebral Small-Vessel Disease: Data From the Significance of Hemodynamic and Hemostatic Factors in the Course of Different Manifestations of Cerebral Small-Vessel Disease Study
.
J Ultrasound Med
.
2019
Apr
;
38
(
4
):
975
87
.
[PubMed]
0278-4297
46.
Migrino
RQ
,
Truran
S
,
Karamanova
N
,
Serrano
GE
,
Madrigal
C
,
Davies
HA
, et al.
Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia
.
Am J Physiol Heart Circ Physiol
.
2018
Aug
;
315
(
2
):
H284
90
.
[PubMed]
0363-6135
47.
Peters
N
,
Freilinger
T
,
Opherk
C
,
Pfefferkorn
T
,
Dichgans
M
.
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL
.
J Neurol
.
2008
Aug
;
255
(
8
):
1203
8
.
[PubMed]
0340-5354
48.
de Boer
I
,
Stam
AH
,
Buntinx
L
,
Zielman
R
,
van der Steen
I
,
van den Maagdenberg
AM
, et al.
RVCL-S and CADASIL display distinct impaired vascular function
.
Neurology
.
2018
Sep
;
91
(
10
):
e956
63
.
[PubMed]
0028-3878
49.
Brennan-Krohn
T
,
Salloway
S
,
Correia
S
,
Dong
M
,
de la Monte
SM
.
Glial vascular degeneration in CADASIL
.
J Alzheimers Dis
.
2010
;
21
(
4
):
1393
402
.
[PubMed]
1387-2877
50.
Craggs
LJ
,
Fenwick
R
,
Oakley
AE
,
Ihara
M
,
Kalaria
RN
.
Immunolocalization of platelet-derived growth factor receptor-β (PDGFR-β) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
.
Neuropathol Appl Neurobiol
.
2015
Jun
;
41
(
4
):
557
70
.
[PubMed]
0305-1846
51.
Tachibana
H
,
Washida
K
,
Kowa
H
,
Kanda
F
,
Toda
T
.
Vascular Function in Alzheimer’s Disease and Vascular Dementia
.
Am J Alzheimers Dis Other Demen
.
2016
Aug
;
31
(
5
):
437
42
.
[PubMed]
1533-3175
52.
Moser
DJ
,
Miller
IN
,
Hoth
KF
,
Correia
M
,
Arndt
S
,
Haynes
WG
.
Vascular smooth muscle function is associated with initiation and processing speed in patients with atherosclerotic vascular disease
.
J Int Neuropsychol Soc
.
2008
Jul
;
14
(
4
):
535
41
.
[PubMed]
1355-6177
53.
Gomis
M
,
Sobrino
T
,
Ois
A
,
Millán
M
,
Rodríguez-Campello
A
,
Pérez de la Ossa
N
, et al.
Plasma β-amyloid 1-40 is associated with the diffuse small vessel disease subtype
.
Stroke
.
2009
Oct
;
40
(
10
):
3197
201
.
[PubMed]
0039-2499
54.
Kong
XD
,
Zhang
Y
,
Liu
L
,
Sun
N
,
Zhang
MY
,
Zhang
JN
.
Endothelial progenitor cells with Alzheimer’s disease
.
Chin Med J (Engl)
.
2011
Mar
;
124
(
6
):
901
6
.
[PubMed]
2542-5641
55.
Nelson
JW
,
Young
JM
,
Borkar
RN
,
Woltjer
RL
,
Quinn
JF
,
Silbert
LC
, et al.
Role of soluble epoxide hydrolase in age-related vascular cognitive decline
.
Prostaglandins Other Lipid Mediat
.
2014
Oct
;
113-115
:
30
7
.
[PubMed]
1098-8823
56.
Duering
M
,
Konieczny
MJ
,
Tiedt
S
,
Baykara
E
,
Tuladhar
AM
,
Leijsen
EV
, et al.
Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
.
J Stroke
.
2018
May
;
20
(
2
):
228
38
.
[PubMed]
2287-6391
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.